Curaleaf Holdings (CURLF) Amortization of Deferred Charges (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Amortization of Deferred Charges of $3.7 million for Q4 2024, down 12.15% year-over-year from $4.2 million in Q1 2024, and up 20.32% quarter-over-quarter from $3.1 million in Q3 2024.
Curaleaf Holdings (CURLF) Amortization of Deferred Charges (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $3.7 million for Q4 2024.
- In Q4 2024, Amortization of Deferred Charges fell 12.15% year-over-year to $3.7 million; the TTM figure through Dec 2024 stood at $15.1 million (up 297.68% YoY), while the FY2025 annual figure was $19.4 million, up 17.39% from the prior year.
- Amortization of Deferred Charges for Q4 2024 stood at $3.7 million, up from $3.1 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $13.4 million in Q3 2021, with the low at -$19.9 million in Q4 2021.
- The 5-year median for Amortization of Deferred Charges is $3.9 million (2023), against an average of $2.8 million.
- Peak annual rise in Amortization of Deferred Charges reached 4116.16% in 2021, while the deepest fall reached 1098.14% in 2021.
- Curaleaf Holdings' Amortization of Deferred Charges stood at $2.0 million in 2020, then slumped by 1098.14% to -$19.9 million in 2021, then jumped by 103.2% to $636000.0 in 2022, then surged by 561.32% to $4.2 million in 2023, then slipped by 12.15% to $3.7 million in 2024.
- Business Quant data shows CURLF's Amortization of Deferred Charges at $3.7 million in Q4 2024, $3.1 million in Q3 2024, and $4.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Dec 31, 2022 | 636,000.00 |
| Dec 31, 2022 | 636,000.00 |
| Sep 30, 2022 | -16.61 Mn |
| Sep 30, 2022 | -16.61 Mn |
| Jun 30, 2022 | 13.12 Mn |
| Jun 30, 2022 | 13.12 Mn |
| Mar 31, 2022 | 12.51 Mn |
| Mar 31, 2022 | 12.51 Mn |
| Dec 31, 2021 | -19.85 Mn |
| Dec 31, 2021 | -19.85 Mn |
| Sep 30, 2021 | 13.40 Mn |
| Sep 30, 2021 | 13.40 Mn |